Mtor inhibitor drugs

mTOR inhibitor is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 1.5 nM. Important Notice: For research use only. We do not sell to

Knowledge on rare diseases and orphan drugs Search for an orphan drug Rapamycin (mTOR) inhibitor.

Small molecule drugs Calcineurin inhibitors Cyclosporine Tacrolimus Mammalian target of rapamycin (mTOR) inhibitors Inhibitors of nucleotide synthesis.

Members of the first generation of mTOR inhibitors and drugs targeting metabolic alterations have had weak therapeutic efficacy as single agents (for extended reading on mTOR inhibitors, see refs

The second generation of mTOR inhibitors can be classified into two subclasses: (a) mTOR/PI3K dual inhibitors (TPdIs), and (b) mTORC1/mTORC2

Drug Interactions Renin-angiotensin-aldosterone system (RAAS) inhibitors mTOR inhibitors Drugs that increase potassium levels Sacubitril.

Sirolimus (rapamycin, Rapamune). This drug works by interfering with mTOR (mammalian target of rapamycin). mTOR inhibitors are of particular interest in

Mechanistic Target of Rapamycin (mTOR) Inhibitors: mTOR inhibitors such as sirolimus, temsirolimus, and everolimus are CYP3A substrates. Amlodipine is a weak

What is considered an immunosuppressant drug? Corticosteroids Calcineurin inhibitors mTOR inhibitors Inosine monophosphate dehydrogenase